Prestige Consumer Healthcare Inc. revenue by segment PBH

Annual Quarterly

Prestige Consumer Healthcare Inc. splits its revenue 2 ways in its filings. By operating segments, the largest line in Q2 of fiscal 2027, the quarter ended Sep 30, 2026 was North American OTC Healthcare at $271.8 million, 81% of the total. By sales mix, the largest line in Q2 of fiscal 2027, the quarter ended Sep 30, 2026 was Product at $332.9 million, 99% of the total.

USD in millions. The percent under a figure is the change from the same quarter a year earlier.

Line	TTM Sep 30, 2026	Q2 FY2027 Sep 30, 2026	Q1 FY2027 Jun 30, 2026	Q4 FY2026 Mar 31, 2026	Q3 FY2026 Dec 31, 2025	Q2 FY2026 Sep 30, 2025	Q1 FY2026 Jun 30, 2025	Q4 FY2025 Mar 31, 2025	Q3 FY2025 Dec 31, 2024
Revenue	1,167	336	266	282	283	274	250	297	290
Operating segments
North American OTC Healthcare	968 +4.0% share 83.0%	272 +17.8% share 80.8%	226 +6.4% share 85.1%	235 -5.8% share 83.3%	236 -1.4% share 83.2%	231 share 84.2%	213 share 85.2%	249 share 84.0%	239 share 82.3%
International OTC Healthcare	199 +10.9% share 17.0%	64 +48.7% share 19.2%	40 +6.9% share 14.9%	47 -1.0% share 16.7%	48 -7.1% share 16.8%	43 share 15.8%	37 share 14.8%	48 share 16.0%	51 share 17.7%
Sales mix
Product	1,155 +4.1% share 99.0%	333 +21.6% share 99.0%	260 +4.4% share 98.0%	279 -5.9% share 99.0%	283 -2.4% share 99.9%	274 share 99.9%	249 share 99.9%	296 share 99.9%	290 share 99.9%
Oral Care	89 +7.7% share 7.6%	23 share 6.8%	—	24 +2.7% share 8.6%	—	—	—	24 share 8.0%	20 share 6.8%
Product And Service Other	12 +875.7% share 1.0%	3 +860.3% share 1.0%	5 +2032.9% share 2.0%	3 +817.7% share 1.0%	0 +26.7% share 0.1%	0 share 0.1%	0 share 0.1%	0 share 0.1%	0 share 0.1%

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry: Pharmaceutical Preparations (SIC 2834)
Listed as: PBH (NYSE)
Fiscal year ends: March 31
Headquarters: Tarrytown, NY
SEC filer status: Large accelerated filer
SEC CIK: 1295947
Former names: Prestige Brands Holdings, Inc. (until Aug 10, 2018)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.